Search results
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
- 171.52Add to watchlist+2.53 (+1.50%)At close: Fri. Jun 28, 2024 4:02 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open169.99High171.82Low169.05
- Mkt Cap302.88BP/E (TTM)51.05Div & Yield6.20 & 3.61%
- Prev. Close168.9952 Wk. Low132.7052 Wk. High182.89
What analysts are sayingTop storiesAbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD PresenceYahoo Finance · 2 days ago- ABBV +1.50%
AbbVie Insiders Sold US$56m Of Shares Suggesting HesitancyYahoo Finance · 2 days ago- ABBV +1.50%
FDA issues complete response to AbbVie’s NDA for Parkinson’s drugYahoo Finance · 5 days agoRelated stocks
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74.
Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.
May 7, 2024 · AbbVie discovers and delivers innovative medicines and solutions that enhance people’s lives.
Delivering more than medicine. At AbbVie, we believe everyone should have access to quality and affordable medicines if and when they need them. We help patients get the medicines they need by offering various access and support programs. learn more.
Apr 11, 2022 · AbbVie help patients get the medicines and solutions they need through various access and support programs and services, including saving cards, bridge programs and patient assistance programs that provide AbbVie medicines at no cost to eligible patients.
We’re building on our deep expertise and historic legacy in immunology research to explore new disease areas, create a more patient-centric discovery and development process, and offer solutions for more diverse patient populations.